AI-Powered Drug Discovery Services for Pharma & Lifescience

AI-assisted compound design, in-silico simulations, predictive simulation of compound efficacy, and pathway recommendations to support early-stage trial direction.

Yes. You can scope work to a single target, one lead series, or a focused pilot to validate direction before expanding.

We combine predictive simulation of compound efficacy with pathway recommendations, supported by AI-assisted compound design and in-silico simulations where relevant.

AI is used to assist compound design and run in-silico simulations, then add predictive efficacy simulation and pathway recommendations to guide early decisions.

We use a graph-database approach to connect molecular structures, substructures, and lineages so relationships stay queryable and defensible.

We enable self-serve access to key scientific data like assays, molecular structures, and sequencing, reducing manual retrieval and repeated back-and-forth.

It means lineage, masking rules, and metadata tracking are built into the workflow to maintain oversight and support compliance expectations.

Provide the datasets you want analyzed, such as assay data, molecular structure information, and sequencing data.

We keep outputs progression-ready by applying governance practices like lineage, masking, and metadata tracking so data remains usable for analytics and next-step planning.

We apply masking rules and governance practices so sensitive data remains protected while teams can still query and use outputs for decision-making.